IRE ELiT and Pi Medical are entering into a commercial partnership to promote and market the Germanium-68/Gallium-68 generator, Galli Ad. Galli Ad is intended for in vitro radiolabeling of radiopharmaceutical kits and preparations developed for PET imaging. It is approved in 13 European countries and inspired by the principles of using 99mTc generators.

The Galli Ad can be used to diagnose neuroendocrine tumors and prostate-related tumors at an early stage.

IRE ELiT has been active on the Dutch and Flemish markets with the Galli Ad since 2018. By entering into this partnership with PI Medical, Dutch customers will now find it easier to obtain technical assistance quickly. This guarantees high quality in service and expertise.

Below you will find the leaflet and brochure available for download, as well as the Galli Cap and Galli Mov accessories.